MedPath

University of Aberdeen

University of Aberdeen logo
🇬🇧United Kingdom
Ownership
Private
Established
1495-01-01
Employees
1K
Market Cap
-
Website
http://www.abdn.ac.uk

Clinical Trials

170

Active:1
Completed:104

Trial Phases

6 Phases

Early Phase 1:1
Phase 1:4
Phase 2:6
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (99 trials with phase data)• Click on a phase to view related trials

Not Applicable
84 (84.8%)
Phase 2
6 (6.1%)
Phase 1
4 (4.0%)
Phase 3
2 (2.0%)
Phase 4
2 (2.0%)
Early Phase 1
1 (1.0%)

Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity

Not Applicable
Not yet recruiting
Conditions
Breast Cancer
Interventions
Drug: Sodium-glucose transport-2 (SGLT-2) inhibitors
Other: Standard medical treatment
First Posted Date
2025-07-17
Last Posted Date
2025-07-17
Lead Sponsor
University of Aberdeen
Target Recruit Count
70
Registration Number
NCT07070765
Locations
🇬🇧

University of Aberdeen, Aberdeen, United Kingdom

Rebalancing the Fat Content of the Heart and Muscles

Not Applicable
Not yet recruiting
Conditions
Diabetes Mellitus Type 2
Interventions
Drug: Semaglutide administration plus dietary counselling and physical activity encouragement
Drug: Semaglutide plus a personalised and supervised program of resistance and endurance training
First Posted Date
2025-07-15
Last Posted Date
2025-07-15
Lead Sponsor
University of Aberdeen
Target Recruit Count
60
Registration Number
NCT07065383

Sex Hormones as Regulators of the Age- and Sex-dependent Benefits of Caloric Restriction

Not Applicable
Recruiting
Conditions
Overweight and Obese Adults
Healthy
First Posted Date
2025-07-15
Last Posted Date
2025-07-18
Lead Sponsor
University of Aberdeen
Target Recruit Count
75
Registration Number
NCT07065643
Locations
🇬🇧

Rowett Institute, University of Aberdeen, Aberdeen, United Kingdom

How Healthy Are Your Oats?

Not Applicable
Recruiting
Conditions
Mycotoxin Biomonitoring
First Posted Date
2025-07-03
Last Posted Date
2025-07-03
Lead Sponsor
University of Aberdeen
Target Recruit Count
16
Registration Number
NCT07050680
Locations
🇬🇧

Rowett Institute, University of Aberdeen, Aberdeen, United Kingdom

Proving Utility of a New Field-cycling MRI Prototype in Acute Stroke Patients

Not yet recruiting
Conditions
Stroke Acute
First Posted Date
2025-06-04
Last Posted Date
2025-06-04
Lead Sponsor
University of Aberdeen
Target Recruit Count
40
Registration Number
NCT07004140
Locations
🇬🇧

University of Aberdeen, Aberdeen, United Kingdom

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 34
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.